<--- Back to Details
First PageDocument Content
Health / AIDS / Nonoxynol-9 / HIV / Tibotec / Sexually transmitted disease / National Institute of Allergy and Infectious Diseases / BufferGel / Zeda Rosenberg / Microbicides / Microbiology / Medicine
Date: 2012-12-14 15:55:53
Health
AIDS
Nonoxynol-9
HIV
Tibotec
Sexually transmitted disease
National Institute of Allergy and Infectious Diseases
BufferGel
Zeda Rosenberg
Microbicides
Microbiology
Medicine

Add to Reading List

Source URL: www.niaid.nih.gov

Download Document from Source Website

File Size: 612,69 KB

Share Document on Facebook

Similar Documents

TMC207 Tine De Marez, PhD Tibotec WGND, October 26, 2011  TMC207 (R207910): Diarylquinoline- a New Class of

TMC207 Tine De Marez, PhD Tibotec WGND, October 26, 2011 TMC207 (R207910): Diarylquinoline- a New Class of

DocID: 1dDG3 - View Document

AIDS InfoNet  www.aidsinfonet.org Fact Sheet Number 434

AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 434

DocID: RQqA - View Document

Rolf van Heeswijk Tibotec BVBA Generaal de Wittelaan L11 B3 B2800, Mechelen  The pharmacokinetic interaction between famotidine and

Rolf van Heeswijk Tibotec BVBA Generaal de Wittelaan L11 B3 B2800, Mechelen The pharmacokinetic interaction between famotidine and

DocID: RJN0 - View Document

Janssen EMEA  (Europe, the Middle East & Africa) Extraordinary efforts for

Janssen EMEA (Europe, the Middle East & Africa) Extraordinary efforts for

DocID: I852 - View Document

Fall[removed]Tibotec TMC114: A Phase II Randomized, Controlled, Partially Blinded, 48-Week Trial to Investigate

Fall[removed]Tibotec TMC114: A Phase II Randomized, Controlled, Partially Blinded, 48-Week Trial to Investigate

DocID: BmPS - View Document